PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery and Cancer, Imperial College London, London, UK.\', \'School of Life Sciences, University of Essex, Colchester, Essex, UK.\', \'Department of Infectious Diseases, Imperial College London, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK.\', \'Department of Surgery and Cancer, Imperial College London, London, UK. charlotte.bevan@imperial.ac.uk.\', \'Department of Surgery and Cancer, Imperial College London, London, UK. gbrooke@essex.ac.uk.\', \'School of Life Sciences, University of Essex, Colchester, Essex, UK. gbrooke@essex.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-24342-y
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34210968
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34210968>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34210968>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all